114 related articles for article (PubMed ID: 22770891)
41. Co-expression of CD44 and ABCG2 in spheroid body-forming cells of gastric cancer cell line MKN45.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Hepatogastroenterology; 2013; 60(125):975-80. PubMed ID: 23803363
[TBL] [Abstract][Full Text] [Related]
42. Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.
Wu CP; Zhou L; Xie M; Du HD; Tian J; Sun S; Li JY
PLoS One; 2013; 8(6):e65750. PubMed ID: 23776540
[TBL] [Abstract][Full Text] [Related]
43. Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Head Neck; 2012 Jun; 34(6):894-9. PubMed ID: 21850700
[TBL] [Abstract][Full Text] [Related]
44. CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.
Baumann M; Krause M
Clin Cancer Res; 2010 Nov; 16(21):5091-3. PubMed ID: 20861165
[TBL] [Abstract][Full Text] [Related]
45. The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.
Assimakopoulos D; Kolettas E; Patrikakos G; Evangelou A
Histol Histopathol; 2002 Oct; 17(4):1269-81. PubMed ID: 12371152
[TBL] [Abstract][Full Text] [Related]
46. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
Murillo-Sauca O; Chung MK; Shin JH; Karamboulas C; Kwok S; Jung YH; Oakley R; Tysome JR; Farnebo LO; Kaplan MJ; Sirjani D; Divi V; Holsinger FC; Tomeh C; Nichols A; Le QT; Colevas AD; Kong CS; Uppaluri R; Lewis JS; Ailles LE; Sunwoo JB
Oncotarget; 2014 Aug; 5(16):6854-66. PubMed ID: 25149537
[TBL] [Abstract][Full Text] [Related]
47. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
[TBL] [Abstract][Full Text] [Related]
48. The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: a review.
Allegra E; Trapasso S; Pisani D; Puzzo L
Oncology; 2014; 86(4):199-205. PubMed ID: 24800958
[TBL] [Abstract][Full Text] [Related]
49. Identification of CD44+ cancer stem cells in human gastric cancer.
Chen W; Zhang X; Chu C; Cheung WL; Ng L; Lam S; Chow A; Lau T; Chen M; Li Y; Nie Y; Wong BC; Pang R
Hepatogastroenterology; 2013 Jun; 60(124):949-54. PubMed ID: 23478146
[TBL] [Abstract][Full Text] [Related]
50. Comments on 'CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits', Se-Yeong Oh et al., European Journal of Cancer, published online 6 July 2012.
Zheng S; Franzmann EJ
Eur J Cancer; 2013 Oct; 49(15):3380-1. PubMed ID: 23880475
[No Abstract] [Full Text] [Related]
51. Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck.
Chikamatsu K; Takahashi G; Sakakura K; Ferrone S; Masuyama K
Head Neck; 2011 Feb; 33(2):208-15. PubMed ID: 20848440
[TBL] [Abstract][Full Text] [Related]
52. ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.
Murakami K; Umemura N; Adachi M; Motoki M; Ohkoshi E
Exp Ther Med; 2022 Dec; 24(6):722. PubMed ID: 36340608
[TBL] [Abstract][Full Text] [Related]
53. Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.
Grau JJ; Mesía R; de la Iglesia-Vicente M; Williams ES; Taberna M; Caballero M; Larque AB; de la Oliva J; Cordón-Cardo C; Domingo-Domenech J
Oncology; 2016; 90(5):267-72. PubMed ID: 27077749
[TBL] [Abstract][Full Text] [Related]
54. [Cultivation and characterization of tumor spheres generated from human colorectal cancer cell lines].
Zhou JT; Gong RX; Chen XZ; Zhou HJ; Zhu YJ; Liu SR; Huang J; Bi F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):918-22, 926. PubMed ID: 19950614
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of CD133
Wang J; Wu Y; Gao W; Li F; Bo Y; Zhu M; Fu R; Liu Q; Wen S; Wang B
J Cancer; 2017; 8(3):497-506. PubMed ID: 28261352
[No Abstract] [Full Text] [Related]
56. Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors.
Kim HS; Pearson AT; Nör JE
Methods Mol Biol; 2016; 1395():241-9. PubMed ID: 26910078
[TBL] [Abstract][Full Text] [Related]
57. Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.
Ohkoshi E; Umemura N
Int J Oncol; 2017 Feb; 50(2):387-395. PubMed ID: 28035370
[TBL] [Abstract][Full Text] [Related]
58. The Identification of Three Cancer Stem Cell Subpopulations within Moderately Differentiated Lip Squamous Cell Carcinoma.
Ram R; Brasch HD; Dunne JC; Davis PF; Tan ST; Itinteang T
Front Surg; 2017; 4():12. PubMed ID: 28321397
[TBL] [Abstract][Full Text] [Related]
59. Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
Zhang S; Balch C; Chan MW; Lai HC; Matei D; Schilder JM; Yan PS; Huang TH; Nephew KP
Cancer Res; 2008 Jun; 68(11):4311-20. PubMed ID: 18519691
[TBL] [Abstract][Full Text] [Related]
60. Significantly increased expression of OCT4 and ABCG2 in spheroid body-forming cells of the human gastric cancer MKN-45 cell line.
Liu J; Wang L; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R
Oncol Lett; 2013 Oct; 6(4):891-896. PubMed ID: 24137432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
